Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1970 1
1972 2
1973 2
1974 2
1975 1
1976 3
1977 2
1979 4
1980 2
1981 6
1982 1
1983 2
1984 4
1985 3
1986 2
1987 2
1988 1
1989 1
1990 8
1991 6
1992 7
1993 10
1994 14
1995 11
1996 6
1997 10
1998 10
1999 5
2000 7
2001 6
2002 11
2003 7
2004 3
2005 3
2006 2
2007 1
2008 7
2009 2
2010 6
2011 15
2012 30
2013 6
2014 8
2015 4
2016 8
2017 6
2018 9
2019 11
2020 9
2021 9
2022 8
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

304 results

Results by year

Filters applied: . Clear all
Page 1
Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy.
Khaled SK, Claes K, Goh YT, Kwong YL, Leung N, Mendrek W, Nakamura R, Sathar J, Ng E, Nangia N, Whitaker S, Rambaldi A; OMS721-TMA-001 Study Group Members. Khaled SK, et al. Among authors: whitaker s. J Clin Oncol. 2022 Aug 1;40(22):2447-2457. doi: 10.1200/JCO.21.02389. Epub 2022 Apr 19. J Clin Oncol. 2022. PMID: 35439028 Free PMC article. Clinical Trial.
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.
Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, Dalby M, Mistry P, Sen M, O'Toole L, Al Booz H, Dyker K, Moleron R, Whitaker S, Brennan S, Cook A, Griffin M, Aynsley E, Rolles M, De Winton E, Chan A, Srinivasan D, Nixon I, Grumett J, Leemans CR, Buter J, Henderson J, Harrington K, McConkey C, Gray A, Dunn J; De-ESCALaTE HPV Trial Group. Mehanna H, et al. Among authors: whitaker s. Lancet. 2019 Jan 5;393(10166):51-60. doi: 10.1016/S0140-6736(18)32752-1. Epub 2018 Nov 15. Lancet. 2019. PMID: 30449623 Free PMC article. Clinical Trial.
Nasal glioma.
Whitaker SR, Sprinkle PM, Chou SM. Whitaker SR, et al. Arch Otolaryngol. 1981 Sep;107(9):550-4. doi: 10.1001/archotol.1981.00790450026009. Arch Otolaryngol. 1981. PMID: 7271553
Skin tissue engineering using 3D bioprinting: An evolving research field.
Tarassoli SP, Jessop ZM, Al-Sabah A, Gao N, Whitaker S, Doak S, Whitaker IS. Tarassoli SP, et al. Among authors: whitaker s. J Plast Reconstr Aesthet Surg. 2018 May;71(5):615-623. doi: 10.1016/j.bjps.2017.12.006. Epub 2017 Dec 13. J Plast Reconstr Aesthet Surg. 2018. PMID: 29306639 Review.
Cochlear nucleus implants.
Hitselberger WE, House WF, Edgerton BJ, Whitaker S. Hitselberger WE, et al. Among authors: whitaker s. Otolaryngol Head Neck Surg. 1984 Feb;92(1):52-4. doi: 10.1177/019459988409200111. Otolaryngol Head Neck Surg. 1984. PMID: 6422415 No abstract available.
Intraoral molluscum contagiosum.
Whitaker SB, Wiegand SE, Budnick SD. Whitaker SB, et al. Oral Surg Oral Med Oral Pathol. 1991 Sep;72(3):334-6. doi: 10.1016/0030-4220(91)90228-5. Oral Surg Oral Med Oral Pathol. 1991. PMID: 1923422 Review.
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells.
Yankelevich M, Thakur A, Modak S, Chu R, Taub J, Martin A, Schalk D, Schienshang A, Whitaker S, Rea K, Lee DW, Liu Q, Shields AF, Cheung NV, Lum LG. Yankelevich M, et al. Among authors: whitaker s. J Immunother Cancer. 2024 Mar 21;12(3):e008744. doi: 10.1136/jitc-2023-008744. J Immunother Cancer. 2024. PMID: 38519053 Free PMC article. Clinical Trial.
Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells.
Yankelevich M, Thakur A, Modak S, Chu R, Taub J, Martin A, Schalk DL, Schienshang A, Whitaker S, Rea K, Lee DW, Liu Q, Shields A, Cheung NK, Lum LG. Yankelevich M, et al. Among authors: whitaker s. Res Sq [Preprint]. 2023 Nov 9:rs.3.rs-3570311. doi: 10.21203/rs.3.rs-3570311/v1. Res Sq. 2023. PMID: 37986911 Free PMC article. Updated. Preprint.
304 results